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ABSTRACT 
 
The LRRK2 gene was recently found to have multiple mutations that are causative for 
autosomal dominant inherited Parkinson´s disease (PD). Previously, we used Northern 
blot analysis to show that that this gene was expressed in the cerebellum, cerebral 
cortex, medulla, spinal cord, occipital pole, frontal lobe, temporal lobe and caudate 
putamen. However, a more comprehensive map of LRRK2 mRNA localization in the 
central nervous system is still lacking. In this study we have mapped the distribution of 
the mRNA encoding for LRRK2 using non-radioactive in situ hybridization. We 
detected a moderate expression of this PD-related gene throughout the adult mouse 
brain. A stronger hybridization signal was observed in deep cerebral cortex layers, 
superficial cingulate cortex layers, the piriform cortex, hippocampal formation, caudate 
putamen, substantia nigra, the basolateral and basomedial anterior amygdala nuclei, 
reticular thalamic nucleus and also in the cerebellar granular cell layer. Given that 
LRRK2 mRNA is highly enriched in motor systems and also is expressed in other 
systems, we may conclude that mutations in LRRK2 may affect several motor and non-
motor structures that may play an important role in the development of PD. 
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INTRODUCTION 
 
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, 
affecting 2 % of people over 65 years of age. Although the majority of PD cases are 
sporadic, a small percentage is caused solely by mutations in several recently identified 
genes. Despite their low frequency, genes that are causative for PD are extremely 
important since they can highlight the mechanisms and pathways leading to the onset of 
the disease, and foster the identification of new forms of therapeutic treatment. 
The familial variant of PD can be divided into autosomal dominant and autosomal 
recessive forms. The currently identified autosomal dominant forms of PD can be due to  
mutations in the genes encoding α-synuclein (SNCA, PARK1), Ubiquitin Carboxyl-
Terminal esterase L1 (UCH-L1, PARK5) or Dardarin (LRRK2, PARK8); while the 
autosomal recessive variants are caused by mutations in the genes encoding Parkin 
(PRKN, PARK2), DJ-1 (DJ-1, PARK7) and PTEN inducible kinase 1 (PINK-1, 
PARK6). 
Recently our group identified four families from the Basque region in Spain with the 
autosomal dominant PD (Paisan-Ruiz et al., 2005). A multipoint linkage analysis 
showed us that these four families were linked to the PARK8 locus (12p11.2q13.1) 
described by Funayama et al. (2002). By means of systematic sequence analysis, we 
identified segregating mutations in all four Basque families within a 9 kb predicted 
transcript (Paisan-Ruiz et al., 2004). The approved symbol for the gene, LRRK2, is due 
to the presence of both the leucine-rich and MAPKKK domains in the protein. The 
protein is known as Dardarin, a word that originated from the Basque word dardara 
meaning “tremor”. While the expression patterns of previously identified genes such as 
SNCA, PRKN, UCHL-1 and DJ-1 have been reported, those for LRRK2 are yet to be 
investigated. 
An in silico analysis of dardarin using the SMART web site (http://smart.embl-
heidelberg.de) suggested that dardarin is a complex protein belonging to the ROCO 
kinases superfamily (Bosgraaf and Van Haastert, 2003). Proteins belonging to the 
ROCO superfamily stand out because of the existence of two conserved domains: a Roc 
domain (Ras on Complex Proteins) and a COR domain (C-terminal Of Roc). Ras-like 
domains are often involved in rearrangements of actin cytosqueleton, and they also play 
an important role in Ras-mediated cell transformation, cytokinesis, focal adhesion 
formation and MAPK pathway stimulation. In addition to these, a further three domains 
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are also found in dardarin: Leucine Rich Repeats (LRR), a Tyrosine catalytic domain 
and a WD40 domain.  
Our analysis of gene expression by Northern blot previously indicated that LRRK2 gene 
is expressed in cerebellum, cerebral cortex, medulla, spinal cord, occipital pole, frontal 
lobe, temporal lobe and putamen (Paisan-Ruiz et al., 2004). However, a complete map 
of LRRK2 mRNA localization in the central nervous system is still lacking. The 
objective of this study is to provide a complete atlas of LRRK2 mRNA distribution in 
the adult mouse brain. 
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MATERIALS AND METHODS 
 
In situ hybridization 
This work is based on five B2B6 adult male mice. All animal manipulations were 
approved by the Animal Care and Ethics Committee of the CSIC and the School of 
Medicine of the University of Valencia. Animals were ether-anesthetized and 
decapitated. Brains were quickly removed and immersed overnight in a fixative 
containing 4% paraformaldehyde in 0.1M pH 7.4 phosphate buffered saline- 0.01% 
diethyl pyrocarbonate (PBS-DEPC). After immersing the fixed brains in gelatine-
glutaraldehyde for 30-60 minutes, a coronal serial of 50µm thick coronal sections were 
prepared using a vibratome (VT1000M, Leica). 
Chromogenic in situ hybridization was performed as described elsewhere. Briefly, 
coronal sections of adult B2B6 mice were dehydrated and then rehydrated in a graded 
methanol series. Next, they were treated with proteinase K and fixed in 
paraformaldehyde. After this treatment, the sections were prehybridized for 2-16h at 
50ºC prior to incubating them for 3 h at 57ºC with the digoxigenin-labelled probe. After 
removal of non-specific binding by sequential washes of decreasing concentrations of 
SSC, the presence of the LRRK2 mRNA was revealed using an HRP-conjugated anti-
digoxigenin antibody and a chromogenic reaction using nitroblue tetrazolium chloride 
and 5-bromo-4-chloro-3-indolyl phosphate (all reagents from Roche Diagnostics). All 
reagents and materials were treated as necessary to ensure the absence of RNAse 
contamination. 
 
Probe synthesis 
Two in situ hybridization probes were synthesized by means of PCR amplification. 
The probes were amplified from a mouse cDNA library (Invitrogen) that 
recognized a fragment of the LRRK2 gene from codon 1004 to codon 1172 (probe I) 
or a fragment from codon 2013 to codon 2171 (probe II). The oligonucleotides used 
for this amplification were the following: 
LRRK2-PROBE1-F: 5´-ATCATCTAGAGTTGCCTCAGTAGCCACC-3´. 
LRRK2-PROBE1-R: 5´-ATCAGTCGACAAGGTAAGGCAGGCATTG-3´. 
LRRK2-PROBE2-F: 5’-TACGTCTAGAGCGAAGATTGCGGACTAC-3’. 
LRRK2-PROBE2-R: 5’-CACAGATATCCCAACCAGAGAGTCGCAC-3’. 
Simón-Sánchez, 6 
 
The PCR conditions used were two minutes at 95ºC followed by thirty-five cycles of 
thirty seconds at 95ºC, thirty seconds at 58ºC and one minute at 72ºC. After cycling, a 
ten-minute step at 72ºC was performed. For this amplification Pfu turbo polymerase 
was used as per manufacturer´s instructions (Stratagen).  The amplified product was 
resolved on a 2% agarose-TBE gel, extracted the Minilute Gel extraction kit (Qiagen) 
and cloned into the Xba I-Sal I sites of the pBluescript KS-II- vector (Stratagene) using 
the Rapid ligation kit (Roche). The probes were synthesized by linearizing the construct 
with either Xba I (antisense probe) or Sal I (sense probe) followed by in vitro 
transcription with digoxigenin labelled nucleotides using an RNA oligonucleotide 
synthesis kit (Roche). To avoid secondary structure formation, RNA synthesized probes 
were diluted with 50% formamide. Both probes yielded equivalent results, only those 
for probe I are shown. 
 
Relative regional expression. 
To determine the level of the LRRK2 expression in different areas of the brain we 
performed several experiments with different development times (from 2 to 16h). The 
level of expression was then correlated with the time needed to obtain clear staining in 
each of the areas shown in the table. When a clear staining was observed in a particular 
area during the first 2 h of developing, it was assigned a “+++” mark, those areas that 
were clearly stained after 9 h of chromogenic reaction were assigned as “++” whereas 
those stained after 16 h of staining were designated with “+”. Those which revealed no 
staining after 16 h were considered as not being able to express LRRK2 or at least their 
level of expression was not detectable with this particular technique. 
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RESULTS 
 
We studied the LRRK2 mRNA expression in adult mice brains through in situ 
hybridization analysis using digoxigenin-labelled RNA probes. We first confirmed the 
specificity of the probe by comparing the staining pattern of the antisense probe with 
that of the sense probe. The antisense probe showed specific signal patterns, whereas no 
signal was observed with the sense probe. This difference between both probes indicates 
that the antisense probe can specifically hybridize with its corresponding transcript (Fig. 
1). 
As a result we found that LRRK2 mRNA was expressed throughout the mouse brain. As 
summarized in Table 1, signal intensities varied from undetected (-), faint (+), moderate 
(++) and strong (+++). A detailed description of the most relevant findings organized 
into brain areas is as follows: 
Telencephalon 
Different LRRK2 mRNA expression patterns were observed in different cortical areas. 
In some areas, LRRK2 was expressed throughout the six cortical areas and the signal 
intensity depended on the cell density in each layer. This was the case of cingular-
frontal (Fig 2A), temporal (Fig. 2D) or occipital and the medial prefrontal cortex. In 
other areas, LRRK2 was absent or in disperse neurons in specific cortical layers. In the 
hindlimb area of the cortex (Fig. 2B) and in the parietal cortex (Fig. 2C), labelling was 
specifically scattered into the layers II/III and in layer V. 
Within the septal area, LRRK2 mRNA was not expressed in the nucleus triangularis 
septalis and was weakly expressed in the dorsal, ventral and intermediate parts of the 
lateral septal nucleus. However, a strong signal was observed in the horizontal limb of 
the medial septal nucleus, and a less but consistent labelling appeared in its vertical 
division dorsal tenia tecta. Furthermore, this gene was also highly expressed in the 
adjacent septohippocampal nuclei  (Fig. 3A). 
Within the hippocampus, LRRK2 mRNA was abundantly expressed in the pyramidal 
cell layer of Ammon´s horn (CA1, CA2 and CA3) as well as in the granular cell layer of 
the dentate gyrus (Fig. 3B). A strong expression was also observed in disperse neurons 
either located in the molecular or in the radiatum-oriens layers. Strong labelling was 
also observed in the hilar region of the dentate gyrus. 
LRRK2 mRNA was strongly expressed in almost every part of the amygdala except for 
the cortical-superficial area (Fig 3C). Thus, it was strongly expressed in the amygdaloid 
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intercalary gray area, the amygdalostriatal transition area, and it was moderately 
expressed in the amygdalopiriform transition area. With regard to the basal amygdaloid 
nucleus, a very strong LRRK2 expression was observed in the lateral, basomedial, 
basolateral and posterior basal divisions (Fig. 3D). A strong LRRK2 expression was 
noted in the medial amygdaloid nucleus in both the posterodorsal and posteroventral 
parts. LRRK2 expression was also detected in the intraamygdaloid division of the bed 
nucleus of the stria terminalis close to the posterodorsal area of the medial amygdaloid 
nucleus and also in the central amygdala. The cortical nucleus, located proximally to the 
medial amugdaloid nucleus, also expresses LRRK2 mRNA in both the posterolateral 
and posteromedial parts. No signal was seen in the nucleus of the lateral olfactory tract  
or in the cortical amygdala (Fig. 3C) 
LRRK2 mRNA expression was high in the most superficial layers of the piriform 
cortex (Fig. 3E). The olfactory tubercule and the islands of Calleja are located close to 
the piriform cortex, which also showed strong LRRK2 expression (Fig. 3F).  
Within the basal ganglia area, LRRK2 mRNA was detected throughout the striatum, 
whereno patchy differences were observed that can indicate a possible differential 
reaction between striosome and matrix. Interestingly, the globus pallidus was nearly 
devoid of any LRRK2 expression (Fig. 4A). 
 
Diencephalon 
With the exceptions of paraventricular thalamic nucleus (Fig. 4B) and the reticular 
nucleus (Fig 4C), which strongly expresses LRRK2 mRNA, all the nuclei within the 
thalamus moderately expressed this gene (Fig. 4C). Some labelled cells were observed 
in both the medial and lateral geniculate nuclei. 
A strong LRRK2 mRNA expression was also observed in the medial habenular nucleus. 
However, only a very faint expression could be seen in the lateral nucleus (Fig. 4B). 
The zona incerta also contained strongly labelled neurons (Fig 3C). 
With regard to the hypothalamus, an LRRK2 mRNA expression was observed in the 
posterior and dorsal areas, although its expression was very weak in the ventrolateral 
nucleus. The ventromedial hypothalamic nucleus showed a moderate-to-high expression 
in the dorsomedial and central parts but not in the ventrolateral one (Fig. 4D). The 
dorsomedial hypothalamic nucleus showed a high LRRK2 mRNA expression in 
compact, ventral and dorsal parts (Fig. 4D). A scattered reaction was observed in the 
lateral hypothalamic area. 
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In addition to these above-mentioned diencephalic areas, the geniculate, zona incerta 
and subthalamic nucleus also expressed LRRK2 moderately. 
 
Brainstem 
A strong LRRK2 mRNA expression was observed in both the dorsal and ventral tiers of 
substantia nigra pars compacta.In contrast, weak LRRK2 mRNA expression was 
detected throughout the substantia nigra pars reticulata (Fig. 4E). 
The ventral tegmental area and the nucleus of Darkschewitsch moderately expressed 
LRRK2 mRNA. A strong reaction was observed in the intermediate gray layer of the 
superior colliculus (Fig 4E) and the red nucleus. Moreover, dispersely labelled neurons 
also occurred in the inferior colliculus and the nuclei of the lateral lemniscus. 
The periaqueductal gray also showed disperse staining (Fig. 4E). Moderate labelling 
was detected in the dorsal and in the median raphe nucleus. In contrast, the dorsal 
tegmental nuclei were almost devoid of expression. 
Faint LRRK2 mRNA expression was seen in the anterior, posterior and medial pretectal 
nuclei. Disperse labelling was observed along the reticular formation whereas some 
cells of the pontine nuclei also expressed LRRK2. 
 
Cerebellum 
As seen in figure 4F the granular cell layer of the cerebellum exhibited a moderate 
LRRK2 mRNA expression. On the other hand, neither the Purkinje cell layer nor the 
basal nuclei showed such mRNA expression. 
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DISCUSSION 
Previously, Northern blot analysis showed that LRRK2 is expressed in the cerebellum, 
cerebral cortex, medulla, spinal cord, occipital pole, frontal lobe, temporal lobe and 
putamen (Paisan-Ruiz, et al., 2004). However, a complete and detailed map of LRRK2 
mRNA localization in the central nervous system was still lacking. Thus, with the 
objective of providing a complete atlas of the LRRK2 mRNA distribution, we used in 
situ hybridization analysis with digoxigenin-labelled RNA probes on mice brain coronal 
sections. The results clearly show that LRRK2 mRNA is distributed throughout the 
mouse brain. However, a stronger hybridization signal appears in specific brain regions 
such as the deep cerebral cortex layers, cingulate cortex, piriform cortex, Ammon´s 
horn and dentate gyrus, caudate putamen, substantia nigra, some parts of the amygdala, 
reticular thalamic nucleus or cerebellar granular cell layer. Amongst these high LRRK2 
expression areas, the caudate putamen, the substantia nigra pars compacta and the 
granular cell layer of the cerebellum, are involved in the regulation of motor activity. As 
most clinical PD symptoms are related to motor dysfunction, this expression data may 
indicate a role of LRRK2 in motor activity regulation. Regarding the appearance of 
LRRK2 mRNA in the granular cell layer of the cerebellum, currently cerebellar 
symptoms have not been described in PD patients. Interestingly, several studies have 
related the appearance of parkinsonian motor features (parkinsonism) to the expansion 
of CAG repeats encoding polyglutamine tracts within Spinocerebellar Ataxia-related 
genes (Gwin-Hardy et al., 2000; Simon-Sanchez et al., 2005; Wu et al., 2004). The 
phenotype of these Spinocerebellar Ataxia patients is variable and may cause a disease 
that clinically overlaps with Parkinson's disease. 
Other structures indirectly related to motor activity regulation also express LRRK2 
mRNA. We detected strong hybridization signals in the hippocampus, piriform cortex, 
cingulate cortex, olfactory tubercle, amygdala or reticular thalamic nucleus. Potential 
relationships between these expression areas and PD pathology have been suggested by 
several groups studying PD and atrophy. Patients with demented PD showed gray 
matter volume decreases in several brain regions such as the putamen, accumbens 
nuclei, some parts of the thalamus, hippocampus or cingulate cortex. Moreover, 
Camicioli et al (2003) found that a hippocampus atrophy was more often displayed in 
PD patients than in healthy subjects regardless of any existing cognitive dysfunction. In 
relation to the amygdala, Junque et al (2005) found that both demented and non-
demented PD patients have clear amygdalar and hippocampal atrophies. Since the 
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amygdala and the hippocampus are key structures of the limbic system, LRRK2 may 
play a role in this function. In this respect, it is interesting to note the absence of 
cognitive dysfunction in most PD patients with dardarin mutations (for example see 
Paisan-Ruiz et al, 2005). 
As we have previously mentioned, we also found a strong LRRK2 mRNA expression in 
the olfactory tubercle and some other olfactory related areas, such as the piriform 
cortex. It could be speculated from this finding that dardarin might play a role in the 
known loss of smell in idiopathic PD (Berendse et al, 2001). 
One important finding from this work that may be relevant to the etiopathogenesis of 
PD, is the strong LRRK2 expression in the putamen which contrasts with a lower or 
non-signal in the globus pallidus. We can speculate that compensatory mechanisms 
between both areas might be disrupted as a consequence of dardarin dysfunction. 
Wszolek and colleagues reported the finding of different pathological signatures in 
brain tissue from four members of a PD family with the R1441C dardarin mutation. 
These authors found Lewy body pathology in two of the four individuals. One of the 
two Lewy body positive patients also had tau inclusions. A third patient of this family 
had solely tau inclusions whereas a fourth one only showed neuronal loss and gliosis in 
the substantia nigra as found in the other three cases (Wszolek, et al., 2004). Our results 
are consistent with this observations in that LRRK2 is expressed in all the areas where 
Wszolek and colleagues found evidence of pathological lesions. Moreover, Gai et al. 
(2005) have recently reported the presence of dardarin in Lewy bodies, neurofibrillary 
tangles and dystrophic neurites in PD, diffuse Lewy body disease, Alzheimer’s disease 
and Multiple System Atrophy suggesting that dardarin could be involved in mechanisms 
leading to neurodegeneration, at least within these disorders. 
In summary, this study demonstrates the existence of LRRK2 mRNA in many brain 
regions and nuclei. These results suggest that mutations in LRRK2 could affect several 
motor structures that playing an important role in PD development. In accord with this, 
most brain regions involved in the nigrostriatal pathway abundantly express LRRK2 
mRNA. The discovery of a strong LRRK2 expression in structures such as the 
hippocampus, amygdala or olfactory tubercle, may indicate that LRRK2 dysfunction 
leads to the appearance of the non-motor symptoms that are characteristic of PD. 
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Abbreviations used in figures. 
APT anterior pretectal nucleus 
Arc nucleus arcuatus 
ASt amygdalostriatal transition area 
BLA basolateral amygdala 
BMA basomedial amygdala 
CA1 field 1 of the Ammon’s horn 
CA3 field 3 of the Ammon’s horn 
CeA central amygdala 
Cg  cingular cortex 
ci capsula interna 
CoA cortical amygdala 
DG dentate gyrus 
DHA dorsal hypothalamic area 
dmVMH dorsomedial division of the ventromedial hypothalamic nucleus 
EW edinger westfal nucleus 
f fornix 
Fr frontal cortex 
GP globus pallidum 
HL  hindlimb cortex 
ICj islands of Calleja 
IL infralimbic medial prefrontal cortex 
InG intermediate gray layer of the superior colliculus 
IP interpeduncular nucleus 
LA lateral amygdala 
LHA lateral hypothalamic area 
LHb lateral habenula 
LOT nucleus of the lateral olfactory tract 
MeA medial amygdala 
MGB medial geniculate body 
MHb medial habenula 
ot optic tract 
PAG periaqueductal gray 
Par parietal cortex 
PFA perifornical area 
Pir piriform cortex 
Pu putamen 
PVP paraventricular posterior thalamic nucleus 
RN red nucleus 
RSG retrosplenial granular cortex 
RT reticular thalamic nucleus 
S subiculum 
SNC substantia nigra pars compacta 
SNR substantia nigra pars reticulata 
Te temporal cortex 
TT tenia tecta 
TuMC tuberal magnocellular division of the lateral hypothalamic area 
VEnd ventral endopiriform division of the claustrum 
vlVMH ventrlateral division of the ventromedial hypothalamic nucleus 
VP ventral pallidum 
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VPL ventral posterolateral thalamic nucleus 
ZI zona incerta 
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ABBREVIATIONS 
LRRK2: Leucine-rich repeat kinase 2 
PD: Parkinson’s disease. 
 Roc domain: Ras on complex proteins. 
COR domain: C-terminal of Roc. 
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Table 1. Relative levels of expression of LRRK2 in adult mouse brain 
Brain area  
  
(I)Telencephalon  
Cerebral cortex ++ 
Olfactory tubercle ++ 
Piriform cortex +++ 
Claustrum + 
  
Hippocampal formation  
Ammon´s horn +++ 
Dentate gyrus +++ 
Septal area  
Tenia tecta ++ 
vertical Medial Septal Nucleus + 
horizontal Medial Septal Nucleus ++ 
Lateral Septal Nucleus + 
Septohippocampal Nucleus ++ 
Nucleus Triangularis Septalis - 
Amygdala and extended amygdala  
Amygdaloid intramedullary gray +++ 
Amygdalopiriform transition area ++ 
Amygdalostriatal transition area +++ 
Basolateral amygdaloid nucleus +++ 
Basomedial amygdaloid nucleus +++ 
Central amygdaloid nucleus + 
Medial amygdaloid nucleus +++ 
Lateral amygdaloid nucleus ++ 
Nucleus of the lateral olfactory tract - 
Cortical amygdala - 
Bed nucleus of the stria terminalis ++ 
Basal ganglia  
Globus pallidus - 
Caudate putamen +++ 
Nucleus accumbens - 
  
(II) Diencephalon  
Thalamus  
Anterodorsal nucleus ++ 
Reticular nucleus ++ 
Parafascicular nucleus + 
Mediodorsal nucleus ++ 
Centrolateral nucleus + 
Paraventricular nucleus +++ 
Geniculate ++ 
Habenular complex  
Medial nucleus +++ 
Lateral nucleus - 
Subthalamus ++ 
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Zona incerta ++ 
Hypothalamus  
Preoptic nuclei - 
Posterior area + 
Dorsal area + 
Ventrolateral nucleus + 
Ventromedial nucleus ++ 
Dorsomedial nucleus ++ 
  
(III) Brainstem  
Pretectum + 
Ventral tegmental area + 
Red nucleus ++ 
Nucleus of Darkschewitsch ++ 
VTA + 
Periaqueductal Gray ++ 
Median Raphe ++ 
Dorsal Raphe ++ 
Dorsal tegmental nuclei - 
Pontine nuclei ++ 
Superior colliculus ++ 
Inferior colliculus + 
  
Substantia nigra  
Pars compacta +++ 
Pars reticulata - 
  
(IV) Cerebellum  
Cerebellar nuclei - 
Cortex  
Purkinge cell layer - 
Granule cell layer ++ 
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Figure legends 
Figure 1.- LRRK2 mRNA expression in the mouse brain. Note that the antisense probe 
(A) shows a specific hybridization pattern and that the sense probe (B) show no 
hybridization signal. The hybridization pattern observed after 2h of developing time is 
shown (C). 
Figure 2.- LRRK2 mRNA expression in different cortical areas, (A) cingular/frontal 
cortical areas, (B) hindlimb cortical area, (C) parietal cortex, and (D) temporal cortex. 
Note that in both the hindlimb and parietal cortices, layers II/III and V showed scattered 
labelling. A long (12h) chromogenic reaction was performed in all these cases. 
Calibration bar 200µm. 
Figure 3.- LRRK2 mRNA distribution in telencephalic areas. (A) Rostral telencephalic 
areas tenia tecta and infralimbic medial prefrontal cortex. (B) Hippocampus, note that 
the nonpyramidal neurons of the Ammons horn (arrows) as well as the hilar neurons 
also express LRRK2. (C) and (D) Amygdala, note the scattered labelling in cortical 
amygdala and the nucleus of the lateral olfactory tract the square in C as magnified in 
D. (E) Piriform cortex, note the strong reaction of the superficial layer. (F) Rostral 
ventral telencephalon showing the islands of Calleja and the ventral striatum. A long 
(12h) chromogenic reaction was performed in all these cases. Calibration bar 200µm. 
Figure 4.- LRRK2 mRNA distribution in subcortical areas. A) Striatum, note the strong 
labelling in the putamen and contrastingly, the specific scattered reaction in the globus 
pallidus. B) habenula and paraventricular thalamic nucleus, contrasting the high signal 
in the medial habenula, the lateral habenula only showed disperse cells. C) Reticular 
thalamic nucleus in the case of a short (2h) chromogenic reaction. D) Ventral tuberal 
region of the hypothalamus, note the scattered labelling in the ventrolateral division of 
the ventromedial hypothalamic nucleus contrasting with the rest of the hypothalamic 
region and areas. E) Midbrain, note the strong reaction in the substantia nigra pars 
compacta and in some midbrain nuclei including the interpeduncular and red nuclei as 
well as the periaqueductal gray and superior colliculus. F) Cerebellum, note the strong 
reaction in the granular layer. A long (12h) chromogenic reaction was performed in all 
the cases except C. Calibration bar 200µm. 
 




